0001104659-16-164586.txt : 20161230 0001104659-16-164586.hdr.sgml : 20161230 20161230162506 ACCESSION NUMBER: 0001104659-16-164586 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161230 FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolf John Peter III CENTRAL INDEX KEY: 0001421915 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 162077825 MAIL ADDRESS: STREET 1: 397 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 3 1 a3.xml 3 X0206 3 2016-12-30 0 0001641640 Nabriva Therapeutics AG NBRV 0001421915 Wolf John Peter III 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 General Counsel and Corp. Sec. Common Shares 270 D Stock Option 2025-09-29 Common Shares 5500 D Stock Option 2026-02-04 Common Shares 5590 D Represented by 2,700 American Depositary Shares. This option was granted on September 30, 2015. Vesting began on September 30, 2015 and ends on September 30, 2019. Twenty-five percent (25%) of the option vested on September 30, 2016, and the remaining seventy-five percent (75%) vests on a monthly pro-rata basis over the remaining vesting period. The exercise price is 84.80 Euro. This option was granted on February 5, 2016. Vesting began on February 29, 2016 and ends on February 29, 2020. Twenty-five percent (25%) of the option will vest on February 28, 2017, and the remaining seventy-five percent (75%) vests on a monthly pro-rata basis over the remaining vesting period. The exercise price is 74.45 Euro. /s/ John Peter Wolf III 2016-12-30